| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.09 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |